Search 1
Entities
LogoName Σ Employees
Fited Fited

Omurga Sağlığınız Önceliğimiz. Kişiye Özel Tasarım 3D Korseniz bir haftada hazır. Ücretsiz ön değerlendirme>05426577406 Fited makes patient-specific 3D printed braces. custom-fit, 3d Printed, medical device, medtech, and healthcare

Type: Startup Activities: healthtech deeptech Technologies: 3D Printing Synthetic Biology

3 0 3 9
AOBiome Therapeutics, Inc. AOBiome Therapeutics, Inc.

AOBiome is focused on transforming human health by developing microbiome-based therapies for inflammatory conditions. AOBiome Therapeutics, Inc. is a Cambridge, MA-based life sciences company focused on transforming human health by developing microbiome-based therapies for local, nasal and systemic inflammatory conditions. Founded in 2012 by PatientsLikeMe founder Jamie Heywood and MIT-trained Chemical Engineer David Whitlock, AOBiome is advancing a pipeline of multiple, clinical-stage therapeutic candidates. The company's portfolio includes multiple clinical-stage programs: a completed Phase 2 study to treat patients with acne vulgaris or acne, a Phase 1b study to treat patients with pediatric eczema (atopic dermatitis), a Phase 2a study …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 0 16
EpiBone, Inc. EpiBone, Inc.

EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 0 28
Kenota Health Kenota Health

Next generation medical devices. Kenota Health makes allergy testing safe, simple and certain. Kenota Health develops next generation medical diagnostic tools. We make allergy testing safe, simple and certain. Diagnostics, Medical Technology, Point of Care, and Allergy

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 28
Venomtech Ltd Venomtech Ltd

Our goal at Venomtech is to lead the way towards an era where venom-based research tools are routinely used as sources Venomtech targeted arrays provide a unique opportunity to identify novel screening tools and discover novel therapeutics. Animal venoms are a complex mix of peptides, small molecules and proteins that bind, activate, inhibit or otherwise modulate molecular targets such as ion channels, GPCRs and kinases. Screening crude venoms to identify bioactive components is made extremely difficult by a large number of potentially conflicting activities (e.g. cytotoxins masking pharmacology) and de-convolution challenges. In the past, these challenges have hampered many of …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 1 8
Healx Healx

AI-powered and patient-inspired. We accelerate the discovery and development of rare disease treatments. Healx is a mission-driven technology company pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this …

Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology

1 0 1 71
Biogelx Biogelx

We design and supply artificial tissue environments for cell culture & bioprinting applications. Biogelx is helping people work in translational science, drug discovery and tissue engineering by 'making in vitro cell cultures more in vivo'​. We do this through manufacturing and supplying 3D cell cultures that can be tuned to specific tissues and synthetic bio-inks that are reproducible, scalable, easy to handle and suitable for clinical decision making. Our portfolio of biomaterials is comprised of synthetic peptide hydrogels that act as extracellular-matrix environments to support cell growth. In addition, the chemical and physical properties of our biomaterials can be precisely …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

2 0 0 2
Enzymlogic Enzymlogic

Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. As experts in the generation and interpretation of kinetic data, we pride ourselves on a proven track record of successful partnerships with worldwide organizations of all sizes, supporting them on a routine basis during the early phases of drug discovery. We use exquisitely tuned assays to deliver accurate, robust and reproducible kinetic data of the highest quality that enhances the identification of compounds with the greatest therapeutic potential. The insight …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 1 12
SureChill SureChill

SureChill is an innovative, once in a generation cooling technology SureChill is a pioneering platform cooling technology that continuously cools for weeks without power. It is innovative and its performance is unrivalled. By harnessing the unique properties of water, it allows continual cooling at a perfect 4oC, anywhere in the world. The technology is saving lives today, and it can help save our planet. Vaccine Refrigerators powered by SureChill technology were first launched into the medical market in 2011, far exceeding the most stringent standards set by the World Health Organization. Today, they’re purchased by the likes of UNICEF, saving …

Type: Startup Activities: healthtech IT Services Technologies: Synthetic Biology

0 0 0 36
Virtus Trading LLC (A Virtus Holding Company) Virtus Trading LLC (A Virtus Holding Company)

Making the difference... VTL has a long proven experience in introducing cutting-edge healthcare equipment and solutions from world-class manufacturers. Their diverse capabilities in Marketing, Sales, Application Support and Service of a wide and comprehensive range of medical equipment and consumables for healthcare facilities, rehabilitation and wellness, makes them a leading solution provider in the region. Established in 2007 with offices in Abu Dhabi, Dubai and Al Ain, Virtus Trading LLC (VTL), from its humble beginnings, today employ more than 30 professionals who have contributed to the 75 Million AED revenue in 2014. VTL offers customers advanced medical management services, medical …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

1 0 1 42
Pharmap Pharmap

[Automatic translation follows] The products of your pharmacy, delivered to your home in 60 minutes Pharmap is the leading pharmaceutical home delivery solution in Italy which allows you to receive any pharmacy product (even prescription drugs) in 1 hour, or in your preferred time slot. The service, born in 2016, now has over 400,000 users in more than 1000 municipalities in Italy (including Milan, Rome, Genoa, Bologna, Florence, Turin, Palermo, Cagliari). More than 2,500 pharmacies manage home deliveries for their customers through Pharmap. In 2019, Pharmap entered the list of the 50 most innovative scale-ups in Italy. Delivery, Pharmacy, and …

Tags: H2020 Type: Startup Activities: consumer services Technologies: Synthetic Biology

1 0 1 47
Digital Orthopaedics Digital Orthopaedics

Clinical decision support systems for musculoskeletal pathologies Digital Orthopaedics is a Digital Health company with the mission to provide a comprehensive Clinical Decision Support System (CDSS) for musculoskeletal pathologies, the foot and ankle in particular. our ambition is to transforms the planning and execution of orthopedic surgeries and treatment with the ultimate goal of Personalizing Orthopedic Treatment through the innovative use of ideation, modeling and 3D simulation. We provide surgeons, patients, and medical devices companies with a state of the art CDSS to identify the optimal treatment and surgical therapeutic plan for each patient and to assist medical device companies …

Type: Startup Activities: healthtech deeptech Technologies: A.I. A.I. - Image Processing A.I. - Machine Learning Synthetic Biology

0 0 0 4
Aspect Biosystems Aspect Biosystems

Developing bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases. bioprinting, tissue …

Type: Startup Activities: deeptech biotech Technologies: 3D Printing New Materials Synthetic Biology

10 0 8 106
VALANX Biotech VALANX Biotech

Superpowering proteins. VALANX Biotech develops a proprietary technology for site-specific protein conjugation for applications in therapeutics, diagnostics and biocatalysis. Bioconjugation, Site-specific conjugation, PEGylation, Biotechnology, and Research and Development

Tags: H2020 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 0 2 10
Hound Labs, Inc. Hound Labs, Inc.

SAFETY + FAIRNESSTM Hound Labs, Inc. develops advanced breath testing technologies to address leading public health and safety issues. The Company’s flagship product, the HOUND® CANNABIS BREATHALYZER, introduces the drug testing industry’s shortest cannabis detection window, giving employers a practical and objective solution to detect and deter recent use. The ultra-sensitive, analytical test identifies active THC molecules in breath, limiting cannabis detection to the workday. As cannabis legalization increases employee access to THC, employers are seeking a solution to continue testing for the drug while balancing workplace safety with employee fairness and privacy. Hound Labs’ groundbreaking innovation returns an objective …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 88
Spiral Therapeutics Spiral Therapeutics

delivering therapies for inner ear disorders We are a clinical stage company delivering therapies for inner ear disorders hearing loss, pharmaceuticals, Meniere's Disease, and drug delivery

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 0 10
Eurofins | Dermscan Pharmascan Eurofins | Dermscan Pharmascan

Assesses your product's future Eurofins Cosmetics & Personal Care is an aligned network of first-class laboratories across Europe, North America, Asia, Oceania and Africa, using the latest technologies and providing an unrivaled range of clinical, sensory, chemical, in vitro and microbiological testing services. Established in 1990 and in continuous expansion ever since, Dermscan joins Eurofins in 2018 in line with Eurofins Cosmetics’ strategy to expand its leading global cosmetic testing footprint. ISO 9001: 2015 certified, Eurofins Dermscan assess the safety, tolerance and efficacy of raw materials, finished products, food supplements, medical devices, etc. Thanks to facilities in France, Poland, Tunisia, …

Type: SMB Activities: biotech cosmetics deeptech Technologies: Synthetic Biology

0 0 0 147
Coral Biome PHARMA Coral Biome PHARMA

CORAL BIOME PHARMA Live cultured corals for Drug discovery Coral Biome is a research and development company dedicated to the discovery of marine natural products of interest for major public health issues such as cancer, inflammation and multi-drug resistant infectious diseases. Our multidisciplinary team of research and worldwide network of collaborators gathers a unique set of competitive expertise including, aquaculture, marine biology, chemistry, cell biology and cancerology to successfully isolate marine natural products and test their biological activity. We maintain a large-scale untapped reservoir of coral species to preserve endangered species, sell corals for aquarium trade (http://www.coralbiome.com/aquaculture/) and provide research …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 2
Zippyware Zippyware

[Automatic translation follows] “Health – Education – Digital”: this is Zippyware’s leitmotif. Our mission ? Ensuring that each of us becomes an actor in our own health through interactive solutions. At Zippyware, we are convinced of the need for prevention in public health and the major role of therapeutic education, in particular through multimedia supports. Digital transformation creates tremendous opportunities to enable as many people as possible to take control of their health. Thanks to our unique combination of medical, educational and technological skills, Zippyware offers fun, innovative, efficient e-health solutions that meet the specific needs of users. Our tools …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

0 0 0 0
mOm Incubators mOm Incubators

Providing global access to high-quality healthcare Just Imagine if there was a way to improve access to affordable high-quality neonatal care worldwide. Just Imagine if neonatal technology was designed to work across different environments, was intuitive to use, easy to set up and simple to maintain. Just imagine if no matter where you are, you have access to the technology that can help save lives mOm is on a mission to rethink how healthcare is delivered and accessed by solving problems from the ground up. We deliver simple, effective and reliable medical devices that can operate anywhere from remote & …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

5 0 5 14
Sarcos Robotics Sarcos Robotics

Sarcos Robotics is now Palladyne AI. Please follow us at https://www.linkedin.com/company/palladyneaicorp Sarcos Technology and Robotics Corporation (NASDAQ: STRC) (NASDAQ: STRCW) is a leader in advanced robotic technology designed to increase the intelligence, efficiency, capability and productivity of advanced robotic systems. Sarcos robotic artificial intelligence and machine learning software enables generalizable autonomy to address challenging, dynamic environments for industries that require a high degree of adaptability and efficiency. For more information, please visit www.sarcos.com robotics, robots, military, robot, aviation, AI/ML software, software, ai software, and ml software

Type: SMB Activities: Industry 4.0 manufacturing military Technologies: Robotics A.I. A.I. - Image Processing Synthetic Biology

2 0 4 208
Piomic Medical Piomic Medical

Advanced wound care, made personal. There are about 50 million reported cases of patients suffering from hard-to-heal wounds, which has created a severe cost burden on global healthcare systems. Piomic developed an innovative medical device for the treatment of hard-to-heal wounds. The COMS® One Therapy System is a portable, hand-held device that incorporates the technologies for optical and magnetic stimulation, intended to promote wound healing in chronic leg and foot ulcers. It integrates smoothly into the patient’s healing journey with usage in all care environments. By developing a therapy that is safe and effective we hope to set a better …

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 16
Surgical Science Surgical Science

On a Mission to Enhance Patient Safety and Healthcare Outcomes With Validated Medical Simulation Training. Surgical Science is a medical simulation company by heart, ran by humans dedicating their actions and passions for people, medicine and technology to enhance patient safety and healthcare outcomes worldwide. Working closely with societies and the medical community, we use advanced technology to create unmatched graphics and haptics for a realistic learning experience. Surgical Science education resources are used in simulation centers, hospitals, universities, and by medical device partners in over 60 countries, helping medical professionals become more skilled and confident. Laparoscopic surgical simulation, Endoscopic …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

0 0 0 179
WHEYD WHEYD

Stomach-friendly Protein Powders Designed for Elite Level Athletes To Improve Performance and Recovery. Simply put, our whey is different to the rest, as is the way we do business and work with suppliers & amazing customers. We provide the highest quality, stomach-friendly, Irish whey protein in delicious flavours, both in single-serve sachets and larger bags. We help those looking to increase their protein intake (20g per portion), while keeping their fat and sugar intake low. By providing the lowest calorie whey protein (86 calories a portion), sustainably sourced from Irish dairy cows, we aim to revolutionise the world of whey …

Type: Startup Activities: healthtech sporttech Technologies: Synthetic Biology

0 0 0 2
Cellomatics Biosciences Ltd Cellomatics Biosciences Ltd

Our expertise, Your discovery Cellomatics Biosciences Ltd. (www.cellomaticsbio.com) is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas. Based at Colwick Quays Business Park, Nottingham UK, our experienced scientific team offers bespoke and innovative preclinical in vitro bioassay services to support our client’s drug development programmes. We work with diverse group of global clients including early start-ups, virtual/small to medium sized Biotechnology and Pharmaceutical companies. Multiplex Immunoassay, Target and biomarker validation, In vitro functional assays, Molecular Biology, Receptor binding, Toxicity testing, Immuno-Oncology, Oncology, Immunology, Inflammation, and Respiratory

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 0 20
LabGenius LabGenius

Combining human and machine intelligence to accelerate the discovery of advanced medicines. LabGenius is the first biopharmaceutical company developing next generation protein therapeutics using a machine learning-driven evolution engine (EVATM). Our protein engineering platform integrates several bleeding edge technologies from the fields of machine learning, synthetic biology and robotics. Synthetic Biology, Protein Engineering, Artificial Intelligence, Machine Learning, High Throughput Screening, Medical, Health, DNA Libraries, drug discovery, and protein therapeutics

Type: Startup Activities: healthtech deeptech biotech Technologies: A.I. - Machine Learning A.I. Robotics Synthetic Biology

7 0 5 59
HiProMine S.A. HiProMine S.A.

Sustainable and eco-friendly solutions to provide nutritious products based on novel protein source. HiProMine S.A. specializes in insect based raw materials production for livestock and companion animals. We offer high quality insect meal (dry form), insect pulp (fresh meat), and insect dried larvae, produced from Black Soldier Fly - Hermetia illucens. Our meals are dried and processed in low temperature which improves digestibility and nutritive values for animals. Our production is compliant with veterinary control standards, biosecurity, prevention of diseases, and GMP+/HACCP rules. All substrates used in insect rearing are vegetable based and GMO free. Looking to alternative and sustainable …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 53
The EBMT The EBMT

We are a non-profit medical and scientific organisation for cellular and stem cell-based therapies. Join our community! The EBMT is a non-profit medical and scientific organisation established in 1974 which hosts a unique patient registry providing a pool of data to perform studies and assess new trends. We aim to be the connection between patients, researchers and other stakeholders to anticipate the future of cellular and stem cell-based therapies. Our community of healthcare professionals is focused on innovation, research and the advancement of these fields to save and improve the lives of patients with blood-related disorders. Visit www.ebmt.org to learn …

Type: SMB Activities: edtech Technologies: Synthetic Biology

0 0 0 184
Royal Trinity Hospice Royal Trinity Hospice

The local hospice for south west & central London. Together with you to the end of life, making the best of every moment Royal Trinity Hospice is the UK's oldest hospice, and provides expert palliative and end of life care for 2,400 people every year. We are the only specialist palliative care provider for 750,000 people across seven boroughs in central and south-west London. As well as nursing and medical care, we provide support to patients and their friends & families through welfare advice, counselling and bereavement support, physiotherapy and occupational therapy, art therapy and therapeutic massage. We are a …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

0 0 0 235
Lumetrics®, Inc. Lumetrics®, Inc.

Revolutionizing Non-Contact Measurements for your Infrared Products. Lumetrics develops and manufactures non-contact thickness measurement and optical inspection systems for medical, glass, food packaging, ophthalmic, automotive, silicon wafer, and film industries. Our breakthrough precision thickness measurement technology is fast, accurate, flexible, and scalable to most QA laboratories, R&D centers, or production lines. With our personalized service, every client benefits from direct collaboration with our engineers. Lumetrics provides off-the-shelf products as well as custom metrology solutions specifically built to meet your needs. Since 2003, Rochester, N.Y.-based Lumetrics has been developing and manufacturing high-precision thickness measurement and gauging systems for a growing cross-section …

Type: SMB Activities: manufacturing Technologies: Synthetic Biology

0 0 0 26
Modulim Modulim

An ounce of prevention is priceless. Modulim is a pioneer in optical imaging solutions powered by spatial frequency domain imaging (SFDI) for noninvasive tissue and vascular assessment. Powered by SFDI, our Clarifi® Imaging System helps clinicians identify patients at-risk of complications due to microvascular dysfunction. The #ClarifiImagingSystem quantifies and maps five biomarkers of microvascular tissue oxygenation and perfusion. As a result, clinicians can quickly identify at-risk patients for earlier and more timely intervention so they may prevent complications such as diabetic foot ulcers and amputations. With its widespread adoption, our technology solutions have the potential to save limbs and lives, …

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

1 0 1 11
Locus Biosciences, Inc. Locus Biosciences, Inc.

Locus Biosciences, Inc. is a biotechnology company that develops CRISPR-engineered precision antibacterial products. Next generation CRISPR technology for programmed cell death. Focused on developing therapies for infectious disease and the microbiome. Locus Biosciences’ novel approach to precision antimicrobials works by taking advantage of a part of an immune system present in many bacteria called the CRISPR-Cas system. The CRISPR-Cas system protects bacteria from invaders such as viruses by creating small strands of RNA called CRISPR RNAs, which match DNA sequences specific to a given invader. When the CRISPR RNAs find a match, they activate Cas proteins that cut the DNA. …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 0 2 57
BioLife Solutions, Inc. BioLife Solutions, Inc.

A leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies BioLife Solutions is a leading supplier of class-defining cell and gene therapy bioproduction tools and services. Our tools portfolio includes our proprietary CryoStor® and HypoThermosol® biopreservation media for shipping and storage, the ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, high capacity cryogenic storage freezers, Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools. For more information, please visit www.biolifesolutions.com, www.scisafe.com, www.stirlingultracold.com, or www.sextonbio.com and follow BioLife on Twitter. We are a publicly traded company …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

3 0 2 210
ChemoMetec ChemoMetec

We are a worldwide leading manufacturer in cell counting and analysis. Born in Scandinavia, operating globally. ChemoMetec is a worldwide leading manufacturer of cell counting and analysis equipment. We specialize in developing and producing high-precision instrumentation, delivering consistent data for thousands of customers across biotech, pharma and academic segments. We are experiencing exponential growth, as the company strives towards our goal to be the number one provider in Life Sciences. Designed, manufactured and tested in Denmark, our instruments and consumables are built with quality materials and dedicated expert workmanship. Find us on Glassdoor: https://bit.ly/3pjjzTA Manufacturing Cell Counters, Manufacturing Cell Analyzers, …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 182
action medeor e.V. action medeor e.V.

Die Notapotheke der Welt. Founded 1964, the charitable, non-governmental organization action medeor e.V. today is the largest medical aid organization in Europe. action medeor supports around 10.000 healthcare facilities in 140 countries all over the world. Medical facilities receive drugs as well as medical equipment and supplies either at cost price or as donations. Our aid is supplied in co-operation with different church and secular organizations, religious communities, private initiatives and healthcare centers abroad. Based on many years’ experience, action medeor has built up a comprehensive network of facilities in the healthcare sector. Emergency and disaster relief In cases of …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

0 0 0 65
PolarSeal® PolarSeal®

Leading the way in flexible material converting by solving and serving the challenges and needs of our global customers. A medical flexible material converter and contract manufacturer serving global medical device and healthcare companies. From material slitting and die cutting through to lamination and printing, we are able to provide a full end-to-end solution for simple and complex projects. PolarSeal is solely focused on medical device contract manufacturing and healthcare material conversion. Maintaining the highest standards of quality is part of who we are and this fortifies our value of being the TRUSTED ADVISOR. Get in touch : enquiries@polarseal.net Wound …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

2 0 2 45
Crohn's and Colitis Canada | Crohn et Colite Canada Crohn's and Colitis Canada | Crohn et Colite Canada

We aim to cure Crohn's & colitis, & better the lives of everyone impacted by IBD. | Nous visons à guérir Crohn et colite Crohn’s and Colitis Canada is the only national, volunteer-based charity focused on finding the cures for Crohn’s disease and ulcerative colitis, the two main forms of inflammatory bowel disease, and improving the lives of children and adults affected by these diseases. We are one of the top two health charity funders of Crohn’s and colitis research in the world, investing over $127 million in research since 1974, leading to important breakthroughs in genetics, gut microbes, inflammation …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

3 0 3 106
PureTech Health PureTech Health

Giving Life to Science PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 29 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

11 0 5 117
TRIANNI, Inc an AbCellera Company TRIANNI, Inc an AbCellera Company

Exceptional Human Antibody Discovery Technology Trianni, Inc. is a biotech company specializing in human antibody discovery platform technology. We offer the leading in vivo platform enabling efficient discovery of fully-human monoclonal antibodies. The Trianni Mouse offers biologic drug discoverers a best-in-class solution for the isolation of therapeutic antibody candidates. Benefits over older conventional mouse immunization + humanization approaches include superior lead panels with respect to potency and diversity along with speed to the clinic and lower operating costs. We aim to make Trianni’s premium technology available to any Pharma or Biotech company engaged in antibody discovery by offering flexible licenses …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
National Comprehensive Cancer Network® (NCCN®) National Comprehensive Cancer Network® (NCCN®)

An alliance of leading cancer centers devoted to patient care, research, and education. The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. By defining and advancing high-quality cancer care, NCCN promotes the importance of continuous quality improvement and …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

1 0 0 203
NanOlogy NanOlogy

Advancing Intratumoral Drug Therapy Approach: Clinical interest in intratumoral therapy is increasing because of advancements in interventional oncology and growing recognition of the importance of treating the primary tumor across the disease spectrum. Clinical trials are underway by NanOlogy in multiple therapeutic areas to evaluate local delivery of concentrated, sustained chemotherapies to increase solid tumor response, eliminate toxicities associated with systemic agents, and promote favorable immunomodulation. Technology: The NanOlogy commercial scale GMP production platform precipitates dissolved drug substances with sonication and compressed supercritical carbon dioxide to form stable large surface area microparticles (LSAMs) of pure drug containing no excipients or …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 7
Treventis Corporation Treventis Corporation

TREVENTISTM Corporation is dedicated to treating and preventing protein misfolding diseases. We utilize a proprietary, patent-pending discovery engine – Common Conformational Morphology (CCM) – to identify druggable active sites in misfolded protein targets. CCM combines unique in silico models with deep expertise in model development (in vitro, ex vivo, in vivo) to enable rational drug design against misfolded protein targets. Our lead program focuses on anti-misfolding small molecules in tauopathy (3R, 4R, familial mutations and mixed) with relevance to Alzheimer’s disease. We have further CCM-driven efforts in oncology and other neurodegenerative diseases that show the wide utility of our technology …

Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

0 0 0 16
Aptamer Group Aptamer Group

We develop Optimer® binders to enable innovation across the life science industry. Aptamer Group develops Optimer® binders to enable innovation in the life science industry. Get our newsletter: https://aptamergroup.com/newsletter Research and Development, Assay Development, Custom development, Drug development, Custom reagents, Agriculture testing, Aptamers, Biomarker discovery, Affinity ligands, Environmental testing, Affinity chromatography ligands, ADCs / AOCs, QC reagents, Diagnostic tools, and Targeted delivery

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

3 0 3 41
Starpharma Starpharma

Starpharma is a global biopharmaceutical company and a world leader in the development of dendrimers. Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for respiratory viruses, DEP® drug delivery and VivaGel®. Medical Devices, Pharmaceuticals, and Dendrimer Drug Delivery

Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

1 0 1 70
Ionis Pharmaceuticals, Inc. Ionis Pharmaceuticals, Inc.

For more than 30 years, Ionis has been a leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has four marketed medicines and a promising late-stage pipeline highlighted by cardiovascular and neurological franchises. We are guided by world-class scientists and business leaders whose great passion for innovation is equaled only by their focus and commitment to discover, develop and deliver medicines to the patients who depend on us. RNA-Targeted Therapeutics

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1,021
European Academy of Allergy and Clinical Immunology - EAACI European Academy of Allergy and Clinical Immunology - EAACI

Dedicated to science - Committed to your health The European Academy of Allergy and Clinical Immunology (EAACI) is a non-profit organization active in the field of allergic and immunologic diseases such as asthma, rhinitis, eczema, occupational allergy, food and drug allergy and anaphylaxis. EAACI was founded in 1956 in Florence and has become the largest medical association in Europe in the field of allergy and clinical immunology. It includes over 12,000 members from 124 countries, as well as 74 National Allergy Societies. EAACI’s mission is to promote basic and clinical research; to collect, assess and diffuse scientific information; to act …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 147
Cure Leukaemia Cure Leukaemia

We fund the Trials Acceleration Programme (TAP) which delivers & connects patients to blood cancer clinical trials. One person is diagnosed with blood cancer every 14 minutes. Help us to help save more lives and eradicate all forms of blood cancer within the next 15 years. Founded in 2003 by Professor Charlie Craddock CBE and patients Graham Silk and Michael Woolley, Cure Leukaemia helps to bring pioneering drug and transplant treatments to blood cancer patients across the United Kingdom. The charity has committed £3m from 2020-22 to fund the Trials Acceleration Programme (TAP) comprising a network of 12 blood cancer …

Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

6 0 6 20
SIOP Europe, the European Society for Paediatric Oncology (SIOPE) SIOP Europe, the European Society for Paediatric Oncology (SIOPE)

Striving to ensure the best possible care and outcome for all children and adolescents with cancer in Europe. The European Society for Paediatric Oncology (SIOP Europe or SIOPE), is the only pan-European organisation representing all professionals working in the field of childhood cancers. With more than 2500 members across 35 European countries, SIOPE is leading the way to ensure the best possible care and outcomes for all children and adolescents with cancer in Europe. SIOPE’s mission is to increase both the cure rate and the quality of cure for children with cancers. As such, SIOPE’s aim is to support education …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech Technologies: Synthetic Biology

6 0 6 29
Prapela Prapela

Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns. Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns. Based on a field of science called Stochastic Resonance, our precise and gentle stimulation improves breathing rhythm and lung function in newborns. Since 2017, we've received over $8M in awards and grants funding the clinical evaluation of our therapy to improve the treatment of opioid-exposed newborns and preterm infants with apnea of prematurity. Next, we aim to improve the treatment of preterm intermittent hypoxemia and bronchopulmonary dysplasia. For more information, …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

0 0 0 3
TotalWellness TotalWellness

TotalWellness helps inspire healthier living with flexible programs and services that anyone can use. TotalWellness provides tailored corporate and health wellness services to help you deliver better wellness programs to your employees. Services include: biometric screenings, corporate flu shots and a wellness portal which includes a Health Risk Assessment. Since our start in 1998, we’ve worked with companies that are interested in the happiness and health of their employee population. We believe the true value of a wellness program is the long-term positive effect they have on an individual’s life. We ignite change by providing biometric screening experiences worth talking …

Type: SMB Activities: healthtech HRtech Technologies: Synthetic Biology

0 0 0 345
Aeras Aeras

Aeras is a non-profit biotech advancing the development of tuberculosis vaccines for the world. In collaboration with global partners in Africa, Asia, North America and Europe, Aeras is supporting the clinical testing of six experimental vaccines as well as a robust portfolio of earlier stage candidates. Aeras receives funding from the Bill & Melinda Gates Foundation, the UK Department for International Development, and the Netherlands’ Ministry of Foreign Affairs and a range of other governments. Aeras is based in Rockville, Maryland; Cape Town, South Africa; and Beijing, China. tuberculosis, vaccines, clinical trials, vaccine manufacturing, and HIV

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

1 0 1 63
Hyderus Hyderus

As a global leader in healthcare marketing, we strive to connect more customers with medicines, vaccines and diagnostics Hyderus - A FINN Partners company is a specialised consultancy in four areas of communications and policy: 1. The rapid change in how decisions are made about health in Europe and other industrialised societies and how clients can influence these decisions 2. The evolution of public health issues in developing countries; how clients can help to inform the discussion on these problems and; how clients can become involved in finding answers 3. Public thinking about international political and development issues - especially …

Type: SMB Activities: Consulting Technologies: Synthetic Biology

0 0 0 12
Proclinical Staffing Proclinical Staffing

At Proclinical Staffing, our life science recruitment services support our partners with permanent and contract vacancies by connecting them with specialist talent across the globe. Whether you are looking for a recruitment agency to support you with a single vacancy or you need to staff an entire new facility, we extend an expert hand to help you find the highly-skilled people you need. Operating exclusively within life sciences industry – from MedTech and Medical Devices to Pharma and Biotech – our experience, resources and dedication enable us to meet the unique needs of the competitive, fast-paced industry. Our worldwide connections …

Type: SMB Activities: healthtech deeptech biotech HRtech regtech Technologies: Synthetic Biology

2 0 2 64
Value Relations Value Relations

Lavoriamo al vostro fianco per sviluppare relazioni di valore. Value Relations is a strategic consultancy firm with an exclusive focus on the Healthcare sector. When relations matter - to support any player of the Healthcare and Lifesciences (pharma, medical device, scientific societies, Patients groups, public and private hospitals) - Value Relations is present with its services of Public & Government Affairs, Market Access, Patient Advocacy, Communication, and Digital PR. - Value Relations è una società di consulenza strategica con una specializzazione esclusiva nel settore dell’Healthcare. Quando le relazioni contano – per supportare qualsiasi attore dell’Healthcare e Lifesciences (farmaceutica, dispositivi medici, …

Type: SMB Activities: Consulting govtech Technologies: Synthetic Biology

1 0 1 21
Sooma Medical Sooma Medical

Depression treatment at home. Transforming psychiatric and neurological care with accessible therapies. Sooma Oy is developing, manufacturing and marketing a non-invasive therapy devices for neurological and psychiatric disorders (depression and chronic pain). Sooma uses transcranial direct current stimulation (tDCS) technology. Our technology is trusted by over 150 clinics worldwide. We feel that everyone deserves high quality care. With our Sooma therapies, we want to provide an effective and safe way to treat disorders within psychiatry and neurology. We want to offer a safe, drug-free treatment option with minimal side effects, that minimises any discomfort that might otherwise come with treating …

Type: Startup Activities: healthtech deeptech biotech manufacturing Technologies: Synthetic Biology

6 0 5 22
Life Sciences BC Life Sciences BC

“Inspiring Minds Advancing Science” Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry. Biopharmaceuticals, Medical Devices, Medical Technologies, and Digital Health Care

Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

1 0 1 30
Canadian Pharmacists Association Canadian Pharmacists Association

The national voice for Canadian pharmacists Our Mission To empower Canadian pharmacists by providing them with the tools and knowledge they need and to advocate for their essential role in health care. Company Overview CPhA is the national voice for Canadian pharmacists. The pharmacy profession and health care in general are changing, creating new opportunities for pharmacists to focus on providing better patient care. Since 1907 our national, non-profit organization has charted the course through many developments in pharmacy. Advocate for pharmacists as members of the health care team, Support, inform and advocate for members, and Provide evidence-based Canadian drug …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech Technologies: Synthetic Biology

0 0 0 101
Immune Biosolutions inc. Immune Biosolutions inc.

Actor of change Immune Biosolutions is a clinical stage biotech company specializing in discovering and engineering avian and human antibodies for therapeutic and diagnostic applications. Our cutting-edge techniques, including phage display and single B cell screening technologies, enable us to engineer custom-fit immunotherapeutic agents. Our discovery platform is available for biotech and pharma partners, providing access to highly conserved mammalian lineage targets and opening up new possibilities for innovative therapeutics. Our biomanufacturing capacity, which has already supported successful internal clinical trials, is also available for partners in a fee-for-service model. Our internal pipeline includes several discovery programs for various cancer …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 1 27
Società Italiana di Farmacologia - SIF Società Italiana di Farmacologia - SIF

[Automatic translation follows] At the service of health and the citizen: from research to medicines. The Italian Society of Pharmacology (SIF) is a non-profit scientific association, recognized by the Ministry of University and Research. The SIF brings together pharmacologists and pharmacology experts from the Italian academic community, from the world of public and private research and from the pharmaceutical industry. Founded in 1939, today the Society is led by a President-in-Office, a President-Elect, a Past President and a Board of Directors made up of seven members, among whom a Secretary is elected. Mission: • promote research in the field of …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

0 0 0 16
FARMAINDUSTRIA FARMAINDUSTRIA

Innovation for people Created in 1963, Farmaindustria is the National Association of the Pharmaceutical Industry established in Spain. It brings together most of the innovative pharmaceutical laboratories established in Spain, which accounts for almost all sales of prescription drugs under patent in the country. farmacia, investigación y desarrollo, industria, innovación, salud, sanidad, health, pharma, healthcare, laboratorios, medicamentos, fármacos, pharmaceuticals, medicine, I+D, vacunas, vaccines, and industria farmacéutica

Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

1 0 1 155
Egualia – Industrie Farmaci Accessibili Egualia – Industrie Farmaci Accessibili

A better future. For everyone. Egualia (formerly Assogenerici) is the Italian Federation of Industries for Accessible Medicines which today represents more than fifty companies, over 95% of the companies producing generic, biosimilar and value-added medicines. Founded in 1993, it is a member of the European association of the sector, Medicines for Europe, and welcomes multinational and Italian companies present throughout the territory, which produce both for the domestic and foreign markets, as well as companies engaged in the production of drugs on behalf of third parties for the entire pharmaceutical industry. Generics and biosimilars cover 80% of therapeutic areas and …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

7 0 7 18
Blueprint Medicines Blueprint Medicines

Striving to improve and extend patient lives Blueprint Medicines is a fully integrated, commercial-stage, global biopharmaceutical company that invents life-changing medicines in two core, strategic areas of allergy/inflammation and oncology/hematology. We pursue discovery, development, and commercialization of therapies that potently and selectively target known drivers of disease, with focused investment in therapeutic areas where we can leverage our core expertise and business infrastructure to bring scale to our science. We are bringing an approved medicine to people living with systemic mastocytosis (SM) in the U.S. and Europe. Additionally, we have a pipeline of research and development programs that range from …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

5 0 2 708
XenTech XenTech

Premium quality preclinical oncology CRO, pioneering the PDX technology for more than 16 years. XenTech is Biotech/Contract Research Organization (CRO) dedicated to translational research in oncology which offers preclinical services to evaluate the anti-cancer potential of drug candidates (PDX, CDX,...) In addition, XenTech develops internal R&D programs to correlate drug response with molecular features of tumors and identify cancer biomarkers and therapeutic targets. patient-derived tumor xenograft models, oncology, biomarkers, efficacy preclinical studies, PDX, CDX, in vivo, and in-vitro assays

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

2 0 2 33
Point of Care Diagnostics Point of Care Diagnostics

Answers when you need them POCD are changing the way healthcare is delivered by sourcing the finest quality technology and brining it to Australia and New Zealand for all medical professionals to take advantage of. We are passionate about providing specialist services in near‐patient diagnostics and in‐vitro testing - including equipment and products tailored to the requirements of our customers. We have extensive experience in the following forms of equipment and product delivery: * Supply of laboratory consumables * Supporting corporate health programs * Running state‐wide public health initiatives * Implementing national pharmacy health programs The company began operations in …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

0 0 0 8
Helsinn Group Helsinn Group

Building quality cancer care together Welcome to Helsinn’s LinkedIn page. This account shall only be used to share (*) news concerning Helsinn. We would like to emphasize that due to the highly regulated nature of the pharma industry, we cannot engage with you online in any discussions concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional Helsinn is a fully integrated, global biopharma company headquartered in Lugano, Switzerland. It is focused on improving the lives of cancer patients all over the world …

Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

0 0 0 397
fisio360 fisio360

[Automatic translation follows] At physio360 physiotherapy centers you will find specialized care only from physiotherapists The physio360 physiotherapy clinics put at your service modern facilities with the highest technology and certified physiotherapists with extensive experience and continued training. The philosophy of our center is to provide individualized and personalized treatment, since all pathologies are not the same nor do all people have the same needs. physiotherapy, Therapeutic Massage, Osteopathy, and franchise

Type: Startup Activities: healthtech Technologies: Synthetic Biology

0 0 0 12
RTI Health Solutions RTI Health Solutions

Providing the trusted research and strategic planning services you need for your drug or medical device. RTI Health Solutions'​ integrated project teams are here to help you with your pharmaceutical and medical device research needs. Our robust and trusted methods provide answers to the research questions relevant to your drug or device. Our experienced teams are with you throughout your product's lifecycle to ensure you have the evidence you need when you need it. They continuously monitor your portfolio of projects to keep them flowing seamlessly—enabling you to focus your time elsewhere. Follow us @RTIHS on Twitter too. We are …

Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

2 0 2 350
AESEG AESEG

[Automatic translation follows] We are the association of the pharmaceutical industry of generic medicines in Spain. AESEG is the association of the pharmaceutical industry of generic medicines in Spain and the qualified business interlocutor in this matter. All pharmaceutical specialty laboratories, pharmaceutical raw material and active ingredient manufacturing companies, or technological development companies whose main activity is carried out in the field of generics within the national territory can be members of AESEG. AESEG was established in Barcelona on March 17, 1998 as a national non-profit organization to promote the knowledge and use of generic medicines, creating a true generic …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 11
Atomo Diagnostics Atomo Diagnostics

Empowering Healthcare Consumers Atomo Diagnostics is a medical device manufacturer headquartered in Sydney, Australia with offices in South Africa and the United Kingdom. Atomo Diagnostics was established to capitalise on a core belief that healthcare products offering significantly improved levels of convenience, simplicity and user experience are disproportionately disruptive and have the potential to be very successful commercial market entrants. In 2013, Atomo introduced AtomoRapid, a range of safe, simple professional use tests that deliver fast and accurate results in both clinical and community settings. In 2014, AtomoRapid HIV won Best in Show at the Medical Device Excellence Awards (MDEA) …

Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

0 0 0 27
AVEO Oncology AVEO Oncology

Committed to delivering medicines that provide a better life for patients with cancer. AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA® (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology combinations in RCC and other indications, and has other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

1 0 1 190
DCAT (Drug, Chemical & Associated Technologies Association) DCAT (Drug, Chemical & Associated Technologies Association)

The Premier Business Development Association for the Global Bio/Pharmaceutical Manufacturing Value Chain Founded in 1890, the Drug, Chemical & Associated Technologies Association, Inc. (DCAT) is a not-for-profit, corporate member-supported, and volunteer-led global business development association for companies engaged in the Bio/Pharmaceutical manufacturing value chain. DCAT has been providing a life-long collegial community for its Member Companies, and their representatives, for over 130 years. DCAT helps build relationships within its unique member company profile that includes the Bio/Pharmaceutical industry’s entire manufacturing value chain. DCAT creates objective, expert-driven education programs and informational services so its Member Companies can easily gain insight into …

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech edtech Technologies: Synthetic Biology

6 0 6 35
CERENOVUS CERENOVUS

Let's change the TRAJECTORY of stroke TOGETHER CERENOVUS, part of Johnson & Johnson MedTech, is an emerging leader in neurovascular care. Our commitment to changing the trajectory of stroke is inspired by our long heritage and dedication to helping physicians protect people from a lifetime of hardship. CERENOVUS offers a broad portfolio of devices used in the endovascular treatment of hemorrhagic and ischemic stroke. Medical Device, MedTech, Medical Technology, Stroke Care, Stroke Treatment, Neurovascular Care, Mechanical Thrombectomy, and Stroke Solutions

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

1 0 1 315
NDA Group AB NDA Group AB

Let's bring medicines to the world, because the world is waiting NDA is a world-leading regulatory and drug development company, with 25 years of excellence, an extensive portfolio of services, and more than 1600 clients. Over the last three years, NDA Group has supported a quarter of the new medicinal products approved in the US and Europe. Our dedicated team of over 150 consultants combined with the unique NDA Advisory Board provide drug developers with unmatched regulatory expertise, ensuring the safe development of complex & innovative treatments that meet the rigorous requirements of the regulatory agencies. We are a genuine …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

1 0 1 139
Molecular Templates Molecular Templates

Engineering the Next Generation of Therapeutics Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform with unique mechanisms of actions which are highly differentiated from antibody drug conjugates (ADCs). MTEM is developing MT-6402, which is in a Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients; MT-5111, which is in a Phase I clinical trial for the treatment of HER2-positive cancers; and MT-0169, …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 92
Rheos Medicines Rheos Medicines

[Automatic translation follows] Rheos Medicines is a biopharmaceutical company harnessing insights in immunometabolism to develop a novel class of medicines with potential to transform the lives of patients with immune mediated diseases. We are rapidly applying a first-in-field approach in immunometabolism with a comprehensive, systems-biology understanding of the metabolic pathways that drive immune cell function and fate coupled to a biomarker discovery effort with potential to bring precision to the treatment of immune-mediated diseases. Launched in 2018 by Third Rock Ventures with a $60 million Series A financing, Rheos is built on groundbreaking science from pioneers in the field, our …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 23
Kanabo Kanabo

Built for Better Health - Get treatment for Pain management and Mental Health here: https://treat-it.clinic - See a GP Online here: https://thegpservice.co.uk - Shop Kanabo here: https://kanabo.store Kanabo Group plc (LSE:KNB) is a digital health company committed to transforming patient care through its innovative technology platform and specialised treatment offerings. Since its inception, Kanabo has been focused on researching, developing, and commercialising regulated medicinal cannabis-derived formulations and therapeutic inhalation devices. Kanabo's NHS-approved online telehealth platform, The GP Service, provides patients with video consultations, online prescriptions, and primary care services. Leveraging its telehealth capabilities, in 2023, Kanabo launched Treat It, an …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 16
Ikena Oncology Ikena Oncology

Patient-directed oncology therapies across pathways relevant in tumor and immune cells Ikena is a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. Our programs focus on key cancer driver pathways that are well-validated in scientific literature but lack approved or effective therapies and therefore have the potential to address high unmet medical needs. By leveraging our deep understanding of discovery chemistry, translational science, and patient-centric drug development, we have built a deep pipeline of wholly owned and partnered programs focused on genetically defined or biomarker-driven cancers, which …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 1 49
Amicus Therapeutics Amicus Therapeutics

Our passion for making a difference unites us. We are a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. Amicus is the Latin word for friend. This name signifies our collaborative approach to developing medicines by incorporating the patient perspective every step of the way. Our company was founded by an entrepreneur who embarked on a life-long journey to transform the lives of those living with devastating conditions when two of his children were diagnosed with a rare disease. That spirit of empathy, compassion, and tenacity permeates our culture …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 590
Alligator Bioscience AB Alligator Bioscience AB

Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s portfolio includes several promising drug candidates, with the CD40 agonist mitazalimab as its key asset. Furthermore, Alligator is co-developing ALG.APV-527 with Aptevo Therapeutics Inc., several undisclosed molecules based on its proprietary technology platform, Neo-X-PrimeTM, and novel drug candidates based on the RUBYTM bispecific platform with Orion Corporation. Out-licensed programs include AC101/HLX22, in Phase 2 development, by Shanghai Henlius Biotech Inc. and an undisclosed target to Biotheus Inc. Alligator ́s technology platform comprises the proprietary technologies ALLIGATOR-GOLD® and FIND®. ALLIGATOR-GOLD® is a human antibody library containing more …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 69
PIR International PIR International

Executive & Interim Search for Life Sciences PIR International provides innovative senior level recruitment solutions to small and multinational life science organisations. We are recruitment specialists who understand the vision, commercial imperatives and research needs of the world’s leading life science organisations. Based in London, UK, PIR serves clients across the international life science sector, spanning pharma, biotech, diagnostic and medical device companies. Using over 100 years of combined experience and a powerful industry network, we find the right senior talent to drive organisations forward. PIR International specialise in C-suite and senior management roles, whether on a permanent or interim …

Type: SMB Activities: deeptech HRtech biotech healthtech transporttech Technologies: Synthetic Biology

0 0 0 13
Zebra Translations Limited Zebra Translations Limited

Because Not Everything in Life is Black and White We are a long established and experienced translation agency specialising exclusively in medical and pharmaceutical documentation. We have been providing top-quality translations since 1999, the year we formed. Zebra is a member of the Association of Translation Companies (ATC) and Federation of Small Businesses (FSB). Our senior in-house linguists are individual members of the Institute of Translation & Interpreting (ITI) and/or the Chartered Institute of Linguists (CIOL). If there's anything else you would like to know, please visit www.zebratranslations.uk or please call us on +44 (0) 1462 429713, we shall be …

Type: SMB Activities: healthtech deeptech regtech Technologies: Synthetic Biology

0 0 0 5
NanoGenics NanoGenics

Nanogenics is an innovative, research-based biotechnology company that specialises in developing bespoke, peptide-based vectors for gene therapy. Nanogenics is proud to introduce LipTideTM; an exciting custom-built delivery vehicle that can be modified to target different cell types and deliver different payloads for all gene therapy. LipTideTM is a peptide nanoparticle that has already shown excellent in vivo efficacy across a range of models and delivery routes, including nebulised and systemic administration. The peptide component performs two functions: it binds the payload to form the core of the nanoparticle and it also triggers receptors on target cells, which cause the cell …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 1
Agenus Agenus

Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or follow us at @agenus_bio. Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/ Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

1 0 1 297
Emergex Vaccines Emergex Vaccines

A UK biotechnology company developing T cell-priming immune set-point candidates against infectious diseases. Emergex, a clinical-stage, privately-held biotechnology company headquartered in Abingdon, UK, with an operating subsidiary in Doylestown, Pennsylvania, USA, is pioneering the development of 100% synthetic T cell-priming immune set-point vaccine candidates that harness and direct the body’s natural CD8+ T cell immune response to destroy and clear pathogen-infected cells in order to provide protection against some of the world’s most urgent health threats. First indications pursued are against infectious diseases caused by: [i] viruses, amongst which are Betacoronavirus, Dengue Fever and Universal Influenza A, including pandemic influenza, …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

1 0 1 38
ProsFit ProsFit

Our Vision: A world where innovation provides limb wearers a choice of affordable, reliable and desirable prosthetic products and services. Motivation: We aim to play our part in enabling confident mobility, timely rehabilitation, community inclusion, and social integration. Through smart deployment of crucial innovation we want to help build transparent health economics, and attract new talent into the industry. Business model: Supports prosthetic clinic owners to radically improve productivity and user outcomes. Innovation roadmap for transformation of prosthetic service delivery at a global scale. Implementation through scalable business model, sized to fit 20m amputees globally. PandoFit: Proprietary cloud-based cross-platform, modular …

Type: Startup Activities: healthtech deeptech Technologies: 3D Printing Synthetic Biology

0 0 0 8
Medical Alley Medical Alley

Medical Alley is the epicenter of health innovation and care. Medical Alley represents a network of more than 800 healthcare industry organizations working together to change healthcare for the better. Our mission: Activate and amplify healthcare transformation. Medical Alley creates context, connections, and collaborations that elevate the healthcare industry. Our current key initiatives include: Enabling healthcare innovation, elevating business progress, and transforming health equity. Listen to the Medical Alley Podcast at www.medicalalleypodcast.org to hear weekly conversations with healthcare and medtech leaders who are helping make Medical Alley the epicenter of health innovation and care. medical device, pharmaceutical, biopharmaceutical, diagnostics, health …

Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

10 0 9 36
StemTek Therapeutics StemTek Therapeutics

StemTek Therapeutics is a start-up biotechnolgy company dedicated to accelerating drug discovery in cancer using cutting edge technology, world-class science and a stem cell centric point of view for cancer therapy. Our mission is to help design novel treatments for cancer targeting cancer stem cells.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 1
RGL Research RGL Research

Supporting Healthcare Innovation R.G.L Research is a contract research organization (CRO) providing expertise and reliable support to the pharmaceutical industries for conducting Clinical Trials. Our clients and partners include pharmaceuticals, biotechnologies, startups, academic and government organization. R.G.L Research is providing tailored and quality services to help clients and partners bend the cost and time curve of drug development to deliver new alternative product and innovative treatment to improve patients quality of life. R.G.L Research has vast professional experience and academic knowledge in performing clinical trials in Israel as well as developing health product in diverse therapeutic areas of medicine, in …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 0
Plasticell Limited Plasticell Limited

Plasticell is a biotechnology company that develops novel therapies through precise manipulation of stem cells and more differentiated cell types using award-winning combinatorial screening technology. Technolgy Innovate cell-based combinatorial screening technology allows us to develop optimised protocols for cell expansion, cell differentiation, gene transduction, biomolecule production as well as the provision of human cells for use in drug discovery. Pipeline Out therapeutic projects include advanced cell and gene therapies as well as drugs discovered by screening rare human cell types derived from stem cells Visit our website www.plasticell.co.uk for more details. Stem Cell Research, Biotechnology, and High Throughput Stemcell Research

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 12
Array BioPharma Inc. Array BioPharma Inc.

Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC. Small molecule drug discovery and development., oncology, biotechnology, melanoma, and colorectal cancer

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 117
The National Center for Children and Families The National Center for Children and Families

Donate. Volunteer. Make Change. Founded in 1915 as an orphanage in the District of Columbia, NCCF is a private, nonprofit child and family welfare agency with a commitment to serving poor, disadvantaged, abused, neglected and/or abandoned children, youth, and their families. Current program services include emergency shelters and transitional housing for homeless families, a high-intensity therapeutic group home, therapeutic and traditional foster care and adoption, independent living for youth transitioning to adulthood, teen parent services, and community-based prevention services that promote academic achievement, parental involvement, economic and vocational stability, and healthy families. Our programs have become social service models, redefining …

Type: SMB Activities: consumer services Technologies: Synthetic Biology

1 0 1 173
KCAS Bio KCAS Bio

A fast-growing contract research organization (CRO) advancing the latest drug development in human & animal healthcare With its presence in three locations across North America and Europe, KCAS Bio is a leading contract research organization (CRO) employing top scientific talent and providing comprehensive bioanalytical services to the global biopharmaceutical industry from early discovery support through product registration and beyond. The collaboration of the three entities allows for global support in bioanalytical, biomarker, immunogenicity, cellular and molecular assay services along with clinical kitting and sample management. The KCAS family of companies operates in state-of-the-art facilities in the United States and Europe. …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

3 0 1 240
Pet Resource Center of Kansas City Pet Resource Center of Kansas City

Ending pet homelessness through education and supportive services for pet owners in need. SNKC is a 501(c)(3) formed in 2002 that serves the Greater Kansas City Community. You are an important part of our team! Your support decreases the number of homeless, unwanted, and neglected pets in our community and entering our area shelters, as well as increases the quality of care for pets and strengthens the animal-human bond in the Kansas City Community. Mission Statement Our mission is to decrease pet homelessness, increase pet retention, and improve the quality of life for pets through education and supportive services for …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

0 0 0 42
Aratana Therapeutics Inc. Aratana Therapeutics Inc.

Aratana Therapeutics is a wholly owned subsidiary of Elanco Animal Health. Aratana Therapeutics, Inc. (Nasdaq: PETX) is a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats. Our mission is to successfully develop and deliver best-in-class therapeutics, provide comprehensive service to veterinarians and serve as a collaborator of choice for human and animal health companies. We believe our therapeutics are highly differentiated, resolve recognizable needs in compelling markets and have therapeutic profiles superior to the standard of care. Our FDA-approved and commercially available therapeutics include: - A prostaglandin receptor antagonist that specifically targets …

Type: Startup Activities: deeptech biotech manufacturing Technologies: Synthetic Biology

2 0 0 16
Likarda Likarda

Improving the Efficacy of Cellular Therapies Likarda is a biotech company developing enabling technologies to transform the way cell therapies are delivered and optimized. Our revolutionary method to coat cells with stealth hydrogels, called Core Shell Spherification® (CSS), protects cells from destruction, keeping them viable while maintaining them in the intended location within the body. Unlike our competitors, Likarda has developed a library of over 50 different hydrogel formulations that work with Core Shell Spherification®, resulting in the ability to uniquely tailor the coating molecules to the specific requirements of the therapeutic cells themselves. From durable and long-term coatings to …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 0 0 13
Epizyme Epizyme

On August 12, 2022, Epizyme was acquired by Ipsen, expanding Ipsen’s oncology portfolio. Epizyme now operates as an Ipsen company with a shared goal of delivering innovative treatment options to underserved patients. Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Neuroscience is advancing at an unprecedented rate and Ipsen is at the forefront of …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

3 0 2 99
MiNA Therapeutics MiNA Therapeutics

Activating RNA, mastering disease Harnessing an innate mechanism of gene activation, MiNA Therapeutics'​ platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases. Gene activation, RNA therapeutics, Liver disease, and Drug discovery

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

3 0 3 37
Biodesix, Inc. Biodesix, Inc.

Leader in Diagnostic Solutions, providing Testing & Biopharma Services A leading diagnostic solutions company with five Medicare-covered tests for the lung cancer (oncology) healthcare continuum. Partnering with BioPharma companies with our unique portfolio of patented technologies, science, and processes. #proteomics #genomics #liquidbiopsy #bdsx #biodesix #lungcancer #biopharma #biotech #lifesciences Molecular Diagnostics, Predictive, Prognostic and Mutation Tests, Companion Diagnostics, Mass Spectrometry Analysis of Biological Samples, oncology, lung cancer, lung disease, cancer diagnostics, biomarkers, liquid biopsy, ddPCR, Non-Small Cell Lung Cancer, Lung Nodules, Nodule Management, Proteomics, Artificial Intelligence, Genomic Testing, Clinical Trials, Biopharma Services, genomics, and multi-omics

Type: SMB Activities: deeptech biotech Technologies: A.I. Synthetic Biology

2 0 2 241
Syntara Syntara

Syntara is an Australian pharmaceutical research company developing drugs for inflammatory and fibrotic diseases Syntara Limited (ASX:SNT) is a clinical stage drug development company targeting extracellular matrix dysfunction with its world-leading expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. Syntara is managing three phase 2 clinical studies in diseases of high unmet need with a further two potential phase 1c/2 studies being evaluated for 2024. Lead candidate SNT‐5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 63
Zealand Pharma Zealand Pharma

Changing lives with next generation peptide therapeutics Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

2 0 2 319